前言目的研究穴位刺激调控法治疗强迫症的临床疗效。方法将强迫症患者65例分为氯米帕明组33例和穴位刺激调控组32例,进行对照研究。用YaleBrown强迫症量表(YBOCS)评定疗效和不良反应。结果氯米帕明组痊愈率为24.2%(8/33例),显效率为27.3%(9/33例)。穴位刺激调控组痊愈率为37.5%(12/32例),显效率为34.4%(11/32例)。第4周末起两组间的YBOCS评分的差异有显著性(P<0.05),穴位刺激调控组疗效优于氯米帕明组。氯米帕明组不良反应发生率显著高于穴位刺激调控组。结论穴位刺激调控组疗效优于氯米帕明组、不良反应小,安全性好。ObjectiveTostudytheclinicaleffectofacupointstimulatingcontrol(ASC)intreatingobsessivecompulsiveneurosis.MethodsThecomparativestudywasconductedin65patientswithobsessivecompulsiveneurosis,theyweredividedintotwogroups,the33patientsinthecontrolgrouptreatedwithchlorimipramineandthe32inthetestedgrouptreatedwithASC.ThetherapeuticefficacyandadversereactionwereassessedaccordingtothestandardforclinicalefficacyevaluationbyYale-Brownscaleforobsess...
冯斌,刘兰英,徐方忠,陈炯,王佩蓉,陈文松,于恩彦,穴位刺激调控法治疗强迫症患者的临床
浏览 7